121 related articles for article (PubMed ID: 19402814)
1. Hepatitis C education and support in Australian prisons: preliminary findings of a nationwide survey.
Dyer J; Tolliday L
Health Promot J Austr; 2009 Apr; 20(1):37-41. PubMed ID: 19402814
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis C in Australian prisons: a national needs assessment.
Mina MM; Herawati L; Butler T; Lloyd A
Int J Prison Health; 2016; 12(1):3-16. PubMed ID: 26933988
[TBL] [Abstract][Full Text] [Related]
3. Considering treatment-as-prevention scale-up for Australian prisons: a qualitative sub-study of expert stakeholders from the Australian 'surveillance and treatment of prisoners with hepatitis C' project (SToP-C).
Rance J; Lafferty L; Treloar C;
Harm Reduct J; 2021 Apr; 18(1):46. PubMed ID: 33902595
[TBL] [Abstract][Full Text] [Related]
4. Expert stakeholder perspectives on the acceptability of treatment-as-prevention in prison: a qualitative substudy of the 'Surveillance and Treatment of Prisoners with Hepatitis C' project (SToP-C).
Rance J; Lafferty L; Treloar C;
Addiction; 2021 Oct; 116(10):2761-2769. PubMed ID: 33751739
[TBL] [Abstract][Full Text] [Related]
5. "You need a designated officer" - Recommendations from correctional and justice health personnel for scaling up hepatitis C treatment-as-prevention in the prison setting.
Lafferty L; Rance J; Byrne M; Milat A; Dore GJ; Grebely J; Lloyd AR; Treloar C;
Int J Drug Policy; 2022 Aug; 106():103746. PubMed ID: 35636069
[TBL] [Abstract][Full Text] [Related]
6. Harm reduction and women in the Canadian national prison system: policy or practice?
Rehman L; Gahagan J; DiCenso AM; Dias G
Women Health; 2004; 40(4):57-73. PubMed ID: 15911510
[TBL] [Abstract][Full Text] [Related]
7. The furthest left behind: the urgent need to scale up harm reduction in prisons.
Sander G; Murphy F
Int J Prison Health; 2017 Sep; 13(3-4):185-191. PubMed ID: 28914120
[TBL] [Abstract][Full Text] [Related]
8. Harm reduction and viral hepatitis C in European prisons: a cross-sectional survey of 25 countries.
Bielen R; Stumo SR; Halford R; Werling K; Reic T; Stöver H; Robaeys G; Lazarus JV
Harm Reduct J; 2018 May; 15(1):25. PubMed ID: 29751763
[TBL] [Abstract][Full Text] [Related]
9. Prison officers' views about hepatitis C testing and treatment: a qualitative enquiry.
Jack K; Islip N; Linsley P; Thomson B; Patterson A
J Clin Nurs; 2017 Jul; 26(13-14):1861-1868. PubMed ID: 27486922
[TBL] [Abstract][Full Text] [Related]
10. Principles of condom provision programs in prisons from the standpoint of European prison health experts: a qualitative study.
Moazen B; Mauti J; Meireles P; Černíková T; Neuhann F; Jahn A; Stöver H
Harm Reduct J; 2021 Jan; 18(1):14. PubMed ID: 33509200
[TBL] [Abstract][Full Text] [Related]
11. Why is there still hepatitis C transmission in Australian prisons? A case report.
Harkness B; Levy M; Evans R; Wenke J
Harm Reduct J; 2017 Nov; 14(1):75. PubMed ID: 29178927
[TBL] [Abstract][Full Text] [Related]
12. Overview of harm reduction in prisons in seven European countries.
Sander G; Scandurra A; Kamenska A; MacNamara C; Kalpaki C; Bessa CF; Laso GN; Parisi G; Varley L; Wolny M; Moudatsou M; Pontes NH; Mannix-McNamara P; Libianchi S; Antypas T
Harm Reduct J; 2016 Oct; 13(1):28. PubMed ID: 27717368
[TBL] [Abstract][Full Text] [Related]
13. Social capital strategies to enhance hepatitis C treatment awareness and uptake among men in prison.
Lafferty L; Treloar C; Guthrie J; Chambers GM; Butler T
J Viral Hepat; 2017 Feb; 24(2):111-116. PubMed ID: 27778436
[TBL] [Abstract][Full Text] [Related]
14. A framework for management of hepatitis C in prisons.
Spaulding AC; Weinbaum CM; Lau DT; Sterling R; Seeff LB; Margolis HS; Hoofnagle JH
Ann Intern Med; 2006 May; 144(10):762-9. PubMed ID: 16702592
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of an e-learning package to improve understanding of blood-borne viruses amongst prison staff in Wales, UK.
Ellen Perrett S; Erricker M; Lyons M
Int J Prison Health; 2014; 10(1):47-54. PubMed ID: 25763984
[TBL] [Abstract][Full Text] [Related]
16. Enhancing assessment and treatment of hepatitis C in the custodial setting.
Post JJ; Arain A; Lloyd AR
Clin Infect Dis; 2013 Aug; 57 Suppl 2():S70-4. PubMed ID: 23884069
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis C elimination among people incarcerated in prisons: challenges and recommendations for action within a health systems framework.
Akiyama MJ; Kronfli N; Cabezas J; Sheehan Y; Thurairajah PH; Lines R; Lloyd AR;
Lancet Gastroenterol Hepatol; 2021 May; 6(5):391-400. PubMed ID: 33857445
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of a prison outreach clinic for the diagnosis and prevention of hepatitis C: implications for the national strategy.
Skipper C; Guy JM; Parkes J; Roderick P; Rosenberg WM
Gut; 2003 Oct; 52(10):1500-4. PubMed ID: 12970145
[TBL] [Abstract][Full Text] [Related]
19. Prisons, hepatitis C and harm minimisation.
Levy MH; Treloar C; McDonald RM; Booker N
Med J Aust; 2007 Jun; 186(12):647-9. PubMed ID: 17576183
[TBL] [Abstract][Full Text] [Related]
20. Telementoring for hepatitis C treatment in correctional facilities.
Neuhaus M; Langbecker D; Caffery LJ; Taylor M; Garner L; Williams G; Smith AC; Macdonald GA
J Telemed Telecare; 2018 Dec; 24(10):690-696. PubMed ID: 30343659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]